Cite

HARVARD Citation

    Sampson, J. et al. (n.d.). MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit.. European journal of cancer. pp. S6-. [Online]. 
  
Back to record